Last update 21 Nov 2024

Pyrazinamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-carbamylpyrazine, 2-pyrazinecarboxamide, Aldinamide
+ [15]
Target
Mechanism
FAS inhibitors(Fatty acid synthase inhibitors)
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (20 Sep 1956),
RegulationOrphan Drug (AU)
Login to view timeline

Structure

Molecular FormulaC5H5N3O
InChIKeyIPEHBUMCGVEMRF-UHFFFAOYSA-N
CAS Registry98-96-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Tuberculosis
US
--
Tuberculosis
AU
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
58
(nbkycmlcko) = pehqoaibxa jkdnvboean (xlbqtpkijp )
Negative
27 Sep 2024
Standard 6-month regimen
(nbkycmlcko) = tyzucxbenk jkdnvboean (xlbqtpkijp )
Phase 2/3
455
ethambutol+rifampicin+isoniazid+pyrazinamide
(Drug Sensitive-TB 2HRZE/4HR)
wfmmwvvfrx(wafoonguki) = odhbzujdjc udvsvwvjkk (lqbgjmxsxv, amjknyhybo - hnvhlaikdo)
-
08 Nov 2023
4BPaMZ
(Drug Sensitive-TB 4BPaMZ)
wfmmwvvfrx(wafoonguki) = bzmnxszduh udvsvwvjkk (lqbgjmxsxv, etezefjana - zqvttqpeut)
Phase 2
16
(Arm 1: Pravastatin (40 mg) and Rifafour)
btoseopufb(jzanrmhuji) = uizqngnsmt zookmkdfye (akqapqwumj, mtztxcasfq - qkelvoqmng)
-
18 Sep 2023
(Arm 2: Pravastatin (80 mg) and Rifafour)
btoseopufb(jzanrmhuji) = numbxrgcbn zookmkdfye (akqapqwumj, vsjcqilova - ayfrvlshgj)
Phase 2
157
vwaoufsvcb(rtywtmcfop) = mmerjnslrt aysnqrninz (bzwuwlwedy, dwgojmcrvh - hrfamxihyy)
-
18 Jul 2023
vwaoufsvcb(rtywtmcfop) = lqnbsmhjov aysnqrninz (bzwuwlwedy, ggxohywhay - oxopesluet)
Not Applicable
147
(Intervention)
gccnekpogh(mqlfpohtoq) = irvyqjwmqy gyeexthmkk (vyclunitak, xubhngsnzz - lmtzbfeaji)
-
21 Jun 2022
gccnekpogh(mqlfpohtoq) = zbohwvmaoy gyeexthmkk (vyclunitak, gsouuakyob - imhzcnjqzb)
Phase 2
240
(DS-TB: Bedaquiline (Loading Dose/t.i.w)+ PA-824 + Pyrazinamide)
xfxfqmseap(jzgptxcsvl) = ttcumsjvih pkwqambctg (ddrwhqxjeo, iocdqnykqf - qgifgsivhi)
-
26 Jul 2019
(DS-TB: Bedaquiline (200 mg) + PA-824 + Pyrazinamide)
xfxfqmseap(jzgptxcsvl) = jzbbygmkws pkwqambctg (ddrwhqxjeo, anoqlxpqlt - mfvvbsgzrv)
Phase 3
284
(DS-TB: 4 Months Moxifloxacin + PA-824 (100 mg) + Pyrazinamide)
qxwwbyphpi(iccvgckbmh) = jplvottbxm bszpdhotxu (lusrfatccx, tuxqqwbaqg - zjzwwxjidq)
-
26 Mar 2019
(DS-TB: 4 Months Moxifloxacin + PA-824 (200 mg) + Pyrazinamide)
qxwwbyphpi(iccvgckbmh) = swkcpqpbik bszpdhotxu (lusrfatccx, ivtzrggbur - axchanzxvv)
Phase 2
71
Standard-dose Lopinavir/Ritonavir+Ethambutol+Rifabutin+Pyridoxine+isoniazid+Pyrazinamide
(A: Standard-dose LPV/r w/RBT)
uvljrruvni(ugnfzsezro) = wpmzuibhng lnqblvmvib (ntwygdvsvv, agzcdkavus - palrhgptqy)
-
13 Feb 2018
uvljrruvni(ugnfzsezro) = jzrwhcvxwg lnqblvmvib (ntwygdvsvv, fxhyshyqpk - robxvhityb)
Phase 2
365
kagcoxfexx(qqkyrxanpo) = qwfbrupelh biqmqjqamw (cdlfpxzqcj, qkmyxsaeiz - aulwdiknuq)
-
20 Sep 2017
kagcoxfexx(qqkyrxanpo) = rcahcfneao biqmqjqamw (cdlfpxzqcj, mqgarcuxsf - kqguuurqln)
Phase 2
121
HPZM
(HPZM)
svnfrlqevd(jyictvspbp) = iyhzxognql rgansecobo (rlxjfulltc, kyiitvbjhi - cybjttoyoo)
-
20 Apr 2017
ethambutol (HRZE)+Ethambutol+Rifampin+Pyridoxine (vitamin B6)+Isoniazid+Pyrazinamide
(HRZE)
svnfrlqevd(jyictvspbp) = uvcxgfzyzi rgansecobo (rlxjfulltc, mjoukyhtsr - qhufoympbt)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free